Casablanca Capital’s Bausch Health BHC Stock Holding History

Casablanca Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-26,000	Closed	-$3.56M	–	31
2013 Q4	$3.05M	Buy	+26,000	New	+$2.85M	1.22%	12

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casablanca Capital's BHC Position: Q1 2014 in Review

Casablanca Capital sold out of Bausch Health (BHC) in Q1 2014, closing a stake of 26,000 shares — an estimated $3.56M sold.

Casablanca Capital first reported a position in BHC in Q4 2013 and held it in 1 quarter. The position peaked at $3.05M in Q4 2013. 452 funds tracked by Wall St. Rank hold BHC as of Q1 2014.

Casablanca Capital reported no remaining Bausch Health position as of Q1 2014 after selling out during the quarter.
Casablanca Capital sold 26,000 Bausch Health shares in Q1 2014, an estimated $3.56M.
Casablanca Capital first reported a position in Bausch Health in Q4 2013 and held it in 1 quarter.
Casablanca Capital's Bausch Health position peaked at $3.05M in Q4 2013.
452 funds tracked by Wall St. Rank held Bausch Health as of Q1 2014.

Based on Casablanca Capital's 13F filing for Q1 2014, filed 14 May 2014.